Quarterly report pursuant to Section 13 or 15(d)

EQUITY TRANSACTIONS (Details 1)

v3.7.0.1
EQUITY TRANSACTIONS (Details 1)
3 Months Ended
Mar. 31, 2017
$ / shares
shares
Equity Transactions Details 1  
Number of Options Outstanding, Beginning | shares 1,124,900
Number of Options Granted | shares 189,159
Number of Options Outstanding, Ending | shares 1,314,059
Number of Options Outstanding, Exercisable | shares 618,305
Weighted Average Exercise Price Outstanding, Beginning | $ / shares $ 2.15
Weighted Average Exercise Price Granted | $ / shares 1.15
Weighted Average Exercise Price Outstanding, Ending | $ / shares 2.01
Weighted Average Exercise Price Outstanding, Exercisable | $ / shares $ 4.27
Weighted Average Remaining Term, Outstanding 9 years
Weighted Average Remaining Term, Granted 9 years 10 months 24 days
Weighted Average Remaining Term, Outstanding 8 years 11 months 12 days
Weighted Average Remaining Term, Exercisable 8 years 9 months 29 days